L Perrigo
United States PRGO 46 employees Updated 9 July 2026
L Perrigo is a finished-dose manufacturer based in United States. It appears in 17 regulatory filings across 1 regulator, without an active US DMF or CEP on file. Its GMP standing is certified by US FDA. Its most recent recorded inspection, by US FDA, closed on 20 February 2026 as VAI.
2
registered plants
2 with an FDA FEI number
17
filings
across 1 regulators
These figures were checked against the regulators' own files on 25 July 2026
Inspections
8 of 8 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.
Inspection history
- 20 February 2026 VAI US FDA
- 5 December 2025 NAI US FDA
- 19 March 2025 VAI US FDA
- 6 October 2023 NAI US FDA
- 22 October 2019 VAI US FDA
- 17 January 2019 VAI US FDA
- 17 August 2017 NAI US FDA
- 11 December 2014 NAI US FDA
NAI means no action indicated, VAI means voluntary action indicated, and OAI means
official action indicated.
Registered plants
| Site | FDA FEI |
| Holland, United States | 1000518646 |
| Allegan, United States | 1811666 |
Filings and GMP by regulator
| Regulator | Filings | GMP certificates |
| US FDA | 17 | 2 |
Scale
| Year | Revenue | Exports | Destinations |
| 2016 | $800K | Not reported | Not reported |
| 2015 | $800K | Not reported | Not reported |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Comparing suppliers?
Choose your molecules and target markets. L Perrigo comes back tiered against every other
supplier able to file there.
Start for free No sales call.
Open risk flags
- 99 active litigation matters are on record.
- The most recent inspection outcome was VAI, on 20 February 2026.
Sources on this page
- FDA
- Drug master files, establishment registration, inspection classifications
- EDQM
- Certificates of suitability
- EudraGMDP and national regulators
- GMP certificates
- Company filings
- Revenue as reported